CSL BEHRING LLC for CSL BEHRING LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2025 | $330,000 | Replaced |
| 3rd Quarter - Amendment | Oct 30, 2026 | $480,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 1476--Preserving Life-saving Access to Specialty Medicines in America Act (PLASMA Act)--Medicare Part D phase-in of manufacturer liability; Issues related to Medicare Most Favored Nation
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLLEEN MALONEY | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLLEEN MALONEY | — |
Trade (domestic/foreign) TRD
Issues related to trade
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COLLEEN MALONEY | — |
| MARY LACEY REUTHER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.